Suppr超能文献

持续性非卧床腹膜透析液中肌酐测量的干扰取决于葡萄糖和肌酐浓度。

Interference of creatinine measurement in CAPD fluid is dependent on glucose and creatinine concentrations.

作者信息

Mak T W, Cheung C K, Cheung C M, Leung C B, Lam C W, Lai K N

机构信息

Department of Chemical Pathology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.

出版信息

Nephrol Dial Transplant. 1997 Jan;12(1):184-6. doi: 10.1093/ndt/12.1.184.

Abstract

BACKGROUND

High glucose concentration in CAPD fluid is known to interfere with creatinine measurement, which is required for assessment of peritoneal membrane permeability and adequacy of dialysis. Correction formulae have been proposed but they may be method/analyser-dependent. We studied such interference in detail.

METHODS

CAPD fluid was diluted to prepare six specimens with glucose concentrations ranging from 9.1 to 154.4 mmol/l. To each specimen, creatinine standard was added to give five different concentrations from 50 to 800 mumol/l. The 30 specimens were assayed for creatinine with six routine clinical chemistry analysers (Hitachi 911 and 747, Technicon RAXT and SMAC3, Beckman CX7, and Kodak Ektachem 700). Creatinine interference was calculated by subtracting the apparent creatinine concentration with corresponding baseline creatinine concentration (measured at glucose = 9.1 mmol/l) in the same series.

RESULTS

At constant creatinine concentration, interference increased with increasing glucose concentration to varying extents (up to 200%) amongst the six analysers. At constant glucose concentration, interference decreased with increasing creatinine concentration in analysers using the alkaline picrate reaction but increased in the Kodak analyser using enzymatic assay.

CONCLUSION

Interference of creatinine measurement in CAPD fluid is dependent on glucose and creatinine concentrations, and each centre should derive specific correction formulae for its analytical system.

摘要

背景

已知持续性非卧床腹膜透析(CAPD)液中的高葡萄糖浓度会干扰肌酐测量,而肌酐测量对于评估腹膜通透性和透析充分性是必需的。已经提出了校正公式,但它们可能依赖于方法/分析仪。我们对此类干扰进行了详细研究。

方法

将CAPD液稀释以制备六个葡萄糖浓度范围为9.1至154.4 mmol/L的标本。向每个标本中加入肌酐标准品,使其浓度从50至800 μmol/L不等,共得到五个不同浓度。使用六种常规临床化学分析仪(日立911和747、Technicon RAXT和SMAC3、贝克曼CX7以及柯达Ektachem 700)对这30个标本进行肌酐测定。通过用同一系列中相应的基线肌酐浓度(在葡萄糖浓度为9.1 mmol/L时测量)减去表观肌酐浓度来计算肌酐干扰。

结果

在肌酐浓度恒定的情况下,六种分析仪中干扰随葡萄糖浓度升高而不同程度增加(高达200%)。在葡萄糖浓度恒定的情况下,使用碱性苦味酸盐反应的分析仪中干扰随肌酐浓度升高而降低,但在使用酶法测定的柯达分析仪中干扰增加。

结论

CAPD液中肌酐测量的干扰取决于葡萄糖和肌酐浓度,每个中心应为其分析系统推导特定的校正公式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验